SECOND EXTENSION - GRANTED
granted
on 11 Jun 2024
Last Applicant/ Owned by
1150 Marina Village Parkway
Alameda
CA
94501
Serial Number
97420511 filed on 20th May 2022
Registration Number
N/A
Correspondent Address
John Paul Oleksiuk
Filing Basis
1. intent to use
2. intent to use current
3. filed as use application
4. use application currently
Disclaimer
NO DATA
SCRIBE THERAPEUTICS
Scientific and medical research in the fields of genome editing, gene editing, genome engineering, gene modulation, genetic transcriptional regulation, genetic transcriptional modulation, genetic diseases, gene therapy and cell therapy, and genetic engineering research and development of pharmaceuticals, biological preparations, and therapeutic products and services; Design and development of engi Read More
Classification Information
Class [044]
Medical, Beauty & Agricultural Services
Molecular diagnostic services in the nature of genetic testing for medical purposes; Medical diagnostic testing services in the field of human disease and human medical conditions
First Use Date in General
N/A
First Use Date in Commerce
N/A
Class [042]
Computer & Software Services & Scientific Services
Scientific and medical research in the fields of genome editing, gene editing, genome engineering, gene modulation, genetic transcriptional regulation, genetic transcriptional modulation, genetic diseases, gene therapy and cell therapy, and genetic engineering research and development of pharmaceuticals, biological preparations, and therapeutic products and services; Design and development of engineered cells for use in scientific research and in drug discovery and development; Providing medical and scientific research information in the fields of genome editing, gene editing, genome engineering, gene modulation, genetic transcriptional regulation, genetic transcriptional modulation, genetic diseases, gene therapy and cell therapy, and genetic engineering; Molecular diagnostic services in the nature of genetic testing for medical research purposes
First Use Date in General
01st Oct 2020
First Use Date in Commerce
01st Oct 2020
Class [005]
Pharmaceutical Products
Pharmaceutical and biological preparations based on genetic engineering and gene therapy for use in diagnosis, prevention, and treatment of diseases in human therapeutics, namely, diseases caused by genetic mutations and diseases and disorders for which gene modification would ameliorate or cure; Gene therapy products, namely, biological preparations based on engineered cells for medical use for the treatment of diseases caused by genetic mutations and of diseases and disorders for which gene modification would ameliorate or cure related to immuno-oncology, degenerative disorders, traumatic injury, enzyme replacement therapy, and immunology; Pharmaceutical and biological preparations based on gene, genome, and cellular editing, modulation, and modification for use in human therapeutics, namely, for the diagnosis, prevention, and treatment of diseases caused by genetic mutations and of diseases and disorders for which gene modification would ameliorate or cure; Pharmaceutical preparations, namely, therapeutic pharmaceuticals developed through genome modifications for the prevention and treatment of genomic disorders, namely, neurological disorders, Huntington's disease, amyotrophic lateral sclerosis (ALS), front temporal dementia, Alzheimer's, Parkinson's, ataxia, autism, epilepsy, and pain, and also for the prevention and treatment of cardiovascular, peripheral nervous system, endocrine, gastrointestinal, renal, genetic immunological, hepatic, infectious, inflammatory, metabolic, autoimmune, musculoskeletal, neurological, ophthalmological, respiratory, urogenital, urological, and hematologic diseases and disorders, and cancer
First Use Date in General
N/A
First Use Date in Commerce
N/A
Mark Details
Serial Number
No 97420511
Mark Type
No Service Mark
Attorney Docket Number
No 333322-20000
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 15th Dec 2024 | SOU TEAS EXTENSION RECEIVED |
| 13th Jun 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 11th Jun 2024 | SOU EXTENSION 2 FILED |
| 11th Jun 2024 | SOU EXTENSION 2 GRANTED |
| 11th Jun 2024 | SOU TEAS EXTENSION RECEIVED |
| 12th Dec 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 10th Dec 2023 | SOU EXTENSION 1 GRANTED |
| 10th Dec 2023 | SOU EXTENSION 1 FILED |
| 10th Dec 2023 | SOU TEAS EXTENSION RECEIVED |
| 20th Jun 2023 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |